1. Home
  2. KNDI vs MDXH Comparison

KNDI vs MDXH Comparison

Compare KNDI & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNDI
  • MDXH
  • Stock Information
  • Founded
  • KNDI 2002
  • MDXH 2003
  • Country
  • KNDI China
  • MDXH Belgium
  • Employees
  • KNDI N/A
  • MDXH N/A
  • Industry
  • KNDI Auto Manufacturing
  • MDXH
  • Sector
  • KNDI Consumer Discretionary
  • MDXH
  • Exchange
  • KNDI Nasdaq
  • MDXH Nasdaq
  • Market Cap
  • KNDI 91.2M
  • MDXH 93.1M
  • IPO Year
  • KNDI N/A
  • MDXH 2021
  • Fundamental
  • Price
  • KNDI $1.17
  • MDXH $1.84
  • Analyst Decision
  • KNDI
  • MDXH Strong Buy
  • Analyst Count
  • KNDI 0
  • MDXH 2
  • Target Price
  • KNDI N/A
  • MDXH $7.00
  • AVG Volume (30 Days)
  • KNDI 115.4K
  • MDXH 78.5K
  • Earning Date
  • KNDI 03-13-2025
  • MDXH 02-26-2025
  • Dividend Yield
  • KNDI N/A
  • MDXH N/A
  • EPS Growth
  • KNDI N/A
  • MDXH N/A
  • EPS
  • KNDI N/A
  • MDXH N/A
  • Revenue
  • KNDI $118,127,232.00
  • MDXH $84,708,000.00
  • Revenue This Year
  • KNDI N/A
  • MDXH $28.76
  • Revenue Next Year
  • KNDI N/A
  • MDXH $19.91
  • P/E Ratio
  • KNDI N/A
  • MDXH N/A
  • Revenue Growth
  • KNDI N/A
  • MDXH 33.01
  • 52 Week Low
  • KNDI $0.89
  • MDXH $1.55
  • 52 Week High
  • KNDI $2.98
  • MDXH $3.85
  • Technical
  • Relative Strength Index (RSI)
  • KNDI 56.77
  • MDXH 37.47
  • Support Level
  • KNDI $1.06
  • MDXH $1.73
  • Resistance Level
  • KNDI $1.12
  • MDXH $1.90
  • Average True Range (ATR)
  • KNDI 0.06
  • MDXH 0.08
  • MACD
  • KNDI 0.00
  • MDXH -0.00
  • Stochastic Oscillator
  • KNDI 60.87
  • MDXH 40.74

About KNDI Kandi Technologies Group Inc

Kandi Technologies Group Inc is engaged in the development, production, and distribution of electric vehicle (EV) products, EV parts, and off-road vehicle products in the Chinese market. Other product offerings include all-terrain vehicles, go-karts, utility vehicles, battery packs, and other systems. It generates maximum revenue through off-road vehicles. The company generates the majority of its revenue from the United states along with other Countries, followed by China.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

Share on Social Networks: